Anika Therapeutics, Inc.
ANIKNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $293.82M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $9.01$22.88
- Volume (live)
- -
- Avg. volume (3M)
- 98.42K
Anika Therapeutics (ANIK) Stock Price & Financial Analysis
Anika Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $20.60 - $21.45 |
|---|---|
| 52-Week High | $22.88 |
| 52-Week Low | $9.01 |
| Open | $20.87 |
| Volume (last close) | 59.20K |
| Average Volume (3M) | 98.42K |
| Revenue (TTM) | 120.65M |
|---|---|
| Net Income (TTM) | -3.78M |
| Free Cash Flow (TTM) | 562.00K |
| EPS (TTM) | −$0.27 |
| Profit Margin | -3.14% |
| Operating Margin | -4.24% |
| Return on Equity (ROE) | -2.76% |
| Debt to Equity | 0.17 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 293.82M |
|---|---|
| Shares Outstanding | 13.72M |
| Price to Sales (P/S) | 2.44 |
| Price to Book (P/B) | 2.14 |
| EV/EBITDA | 91.73 |
| 50-Day MA | $20.69 |
|---|---|
| 200-Day MA | $15.61 |
| 1-Year Change | +118.55% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Anika Therapeutics at a Glance
As of the Oct 23, 2026 close, Anika Therapeutics (ANIK) has a market capitalization of $293.82M. The stock trades at 2.4× sales. Over the trailing twelve months it lost $3.78M on revenue of $120.65M and generated $562.00K of free cash flow. Revenue grew 5.3% year over year.
As of its latest reported balance sheet, it holds $38.41M in cash and securities against $23.32M of debt, a net cash position of $15.10M.
Anika Therapeutics does not currently pay a dividend.
The share price is up 118.5% over the past year. At $21.42 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $9.01 to $22.88, above its 200-day moving average of $15.61.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Anika Therapeutics
What is the current stock price for ANIK?
As of the Oct 23, 2026 close, ANIK stock trades at $21.42. The 52-week range is $9.01–$22.88, with a day range of $20.60–$21.45.
What is the P/E ratio for ANIK?
The P/E ratio (Price-to-Earnings) for ANIK is shown in the Key Statistics section. This valuation metric helps compare Anika Therapeutics, Inc. to industry peers.
Does ANIK pay dividends?
Anika Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ANIK?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ANIK is Buy.
What is the market cap of ANIK?
As of the Oct 23, 2026 close, Anika Therapeutics's market capitalization is $293.8M, classifying it as a micro-cap company. Anika Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.